Aptamer proteomics of serum exosomes from patients with primary raynaud’s and patients with raynaud’s at risk of evolving into systemic sclerosis

HIGHLIGHTS

• who: Sonsoles Piera-Velazquez and collaborators from the Jefferson Institute of Molecular Medicine, Scleroderma Center of Thomas Jefferson University have published the Article: Aptamer proteomics of serum exosomes from patients with Primary Raynaudu2019s and patients with Raynaudu2019s at risk of evolving into Systemic Sclerosis, in the Journal: PLOS ONE of 19/07/2022
• what: The analysis was performed at the BIDMC Genomics, Proteomics, Bioinformatics, and Systems Biology Center of Beth Israel Deaconess Medical Center (Boston, MA), an experienced SomaLogic certified service provider, according to standard protocols from SomaLogic that have been described elsewhere using exosomes . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.